FDA Approves New Rx for Skin Infections
It's been quite a year for new antibacterial medications. The US Food and Drug Administration (FDA) has just approved the third new medication in 2014 to treat certain skin infections.
FDA Approves Orbactiv to Treat Skin Infections
The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
World Cup Health Issues Highlighted
Global travelers will soon descend upon Brazil, first for this summer's World Cup, then again for the 2016 Summer Olympics. A new report examined health risks for these travelers.
Waiting for Warts to Wane?
Many people simply wait to see if their warts will go away naturally. Others turn to medical treatments for their warts, but these treatments often fail. For this reason, researchers recently studied the progression of warts that underwent different treatment options.
Warts Love Family and Friends
Most of the public health prevention information related to skin warts relates to public places, like swimming pools. But are these really where warts are most commonly passed on?
Shingles Stay Quiet with RA Medicine
Returning outbreaks of shingles are more common in people with rheumatoid arthritis (RA). Until now, researchers were not sure how medicines for RA would affect the chance that the painful rash would return.
Oral Sores Linked with Skin Problem
Inflamed and scaly skin is one thing psoriasis patients may have to deal with on the outside. But patients with this skin disorder may also have to care for certain issues on the inside.
New Rx Fares Well for Skin Infections
A variety of skin infections caused by bacteria are becoming harder to treat. The difficulty occurs when the infection can resist the antibiotic that is supposed to treat it.
For Olympians, Tough Skin is Necessary
Olympic athletes train to be the most mentally and physically tough competitors in their event. But for many, an unexpected condition can threaten a hard earned chance at success.
Shingles Vaccine Safe for More Patients
People taking immunity-suppressing drugs are currently advised against the live-virus shingles vaccine because there is concern that it could lead to shingles, for this population.